CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning Balance (in shares) at Jan. 31, 2021			76,340,000
Beginning Balance at Jan. 31, 2021		$ 1,651,185	$ 764	$ 638,375	$ 1,019,762	$ (7,117)	$ (599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		227,802			227,802
Foreign currency translation adjustments		3,700				3,700
Change in fair value of derivative financial instruments, net of tax		(665)				(665)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		153				153
Conversion/release of stock-based awards (in shares)			686,000
Conversion/release of stock-based awards		(98,451)	$ 7	(97,958)			(500)
Repurchases of common stock (in shares)			(1,791,000)
Repurchases of common stock		(315,529)	$ (18)	(9,239)	(306,272)
Reissuance of treasury stock under stock-based compensation plans		0		(344)	(44)		388
Stock-based compensation expense		25,471		25,471
Dividends declared		(46,370)			(46,370)
Ending Balance (in shares) at May. 02, 2021			75,235,000
Ending Balance at May. 02, 2021		1,447,296	$ 753	556,305	894,878	(3,929)	(711)
Beginning Balance (in shares) at Jan. 31, 2021			76,340,000
Beginning Balance at Jan. 31, 2021		1,651,185	$ 764	638,375	1,019,762	(7,117)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		723,396
Foreign currency translation adjustments		970
Change in fair value of derivative financial instruments, net of tax		(654)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		859
Ending Balance (in shares) at Oct. 31, 2021			73,326,000
Ending Balance at Oct. 31, 2021		1,543,370	$ 734	585,449	963,840	(5,942)	(711)
Beginning Balance (in shares) at May. 02, 2021			75,235,000
Beginning Balance at May. 02, 2021		1,447,296	$ 753	556,305	894,878	(3,929)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		246,070			246,070
Foreign currency translation adjustments		(3,522)				(3,522)
Change in fair value of derivative financial instruments, net of tax		65				65
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		337				337
Conversion/release of stock-based awards (in shares)			25,000
Conversion/release of stock-based awards		(1,709)		(1,709)
Repurchases of common stock (in shares)			(834,000)
Repurchases of common stock		(135,859)	$ (8)	(4,358)	(131,493)
Stock-based compensation expense		19,496		19,496
Dividends declared		(45,455)			(45,455)
Ending Balance (in shares) at Aug. 01, 2021			74,426,000
Ending Balance at Aug. 01, 2021		1,526,719	$ 745	569,734	964,000	(7,049)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		249,524			249,524
Foreign currency translation adjustments		792				792
Change in fair value of derivative financial instruments, net of tax		(54)				(54)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		369				369
Conversion/release of stock-based awards (in shares)	[1]		20,000
Conversion/release of stock-based awards	[1]	(2,322)		(2,322)
Repurchases of common stock (in shares)			(1,120,000)
Repurchases of common stock		(201,311)	$ (11)	(5,921)	(195,379)
Stock-based compensation expense		23,958		23,958
Dividends declared		(54,305)			(54,305)
Ending Balance (in shares) at Oct. 31, 2021			73,326,000
Ending Balance at Oct. 31, 2021		1,543,370	$ 734	585,449	963,840	(5,942)	(711)
Beginning Balance (in shares) at Jan. 30, 2022			71,982,000
Beginning Balance at Jan. 30, 2022		1,664,207	$ 720	600,942	1,074,084	(10,828)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		254,113			254,113
Foreign currency translation adjustments		(1,514)				(1,514)
Change in fair value of derivative financial instruments, net of tax		93				93
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(18)				(18)
Conversion/release of stock-based awards (in shares)	[1]		617,000
Conversion/release of stock-based awards	[1]	(78,508)	$ 6	(78,142)			(372)
Repurchases of common stock (in shares)			(3,380,000)
Repurchases of common stock		(501,075)	$ (33)	(18,590)	(482,452)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)			344
Stock-based compensation expense		28,339		28,339
Dividends declared		(55,893)			(55,893)
Ending Balance (in shares) at May. 01, 2022			69,219,000
Ending Balance at May. 01, 2022		1,309,744	$ 693	532,205	789,852	(12,267)	(739)
Beginning Balance (in shares) at Jan. 30, 2022			71,982,000
Beginning Balance at Jan. 30, 2022		1,664,207	$ 720	600,942	1,074,084	(10,828)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		772,911
Foreign currency translation adjustments		(8,057)
Change in fair value of derivative financial instruments, net of tax		1,188
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(151)
Ending Balance (in shares) at Oct. 30, 2022			66,556,000
Ending Balance at Oct. 30, 2022		1,412,934	$ 666	553,698	877,157	(17,848)	(739)
Beginning Balance (in shares) at May. 01, 2022			69,219,000
Beginning Balance at May. 01, 2022		1,309,744	$ 693	532,205	789,852	(12,267)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		267,075			267,075
Foreign currency translation adjustments		(1,385)				(1,385)
Change in fair value of derivative financial instruments, net of tax		26				26
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(5)				(5)
Conversion/release of stock-based awards (in shares)	[1]		26,000
Conversion/release of stock-based awards	[1]	(767)		(767)
Repurchases of common stock (in shares)			(2,188,000)
Repurchases of common stock		(265,349)	$ (22)	(12,519)	(252,808)
Stock-based compensation expense		22,976		22,976
Dividends declared		(54,036)			(54,036)
Ending Balance (in shares) at Jul. 31, 2022			67,057,000
Ending Balance at Jul. 31, 2022		1,278,279	$ 671	541,895	750,083	(13,631)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		251,723			251,723
Foreign currency translation adjustments		(5,158)				(5,158)
Change in fair value of derivative financial instruments, net of tax		1,069				1,069
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(128)				(128)
Conversion/release of stock-based awards (in shares)	[1]		13,000
Conversion/release of stock-based awards	[1]	(1,156)		(1,156)
Repurchases of common stock (in shares)			(514,000)
Repurchases of common stock		(74,531)	$ (5)	(3,010)	(71,516)
Stock-based compensation expense		15,969		15,969
Dividends declared		(53,133)			(53,133)
Ending Balance (in shares) at Oct. 30, 2022			66,556,000
Ending Balance at Oct. 30, 2022		$ 1,412,934	$ 666	$ 553,698	$ 877,157	$ (17,848)	$ (739)

[1] Amounts are shown net of shares withheld for employee taxes.